Advertisement
Advertisement
CARL
Carlsmed, Inc. Common Stock
14.52
USDSponsored
-0.80
-5.22%
Nov 06, 15:59 UTC -5
Closed
After-Market
14.47
-0.04
-0.31%
Carlsmed, Inc. Common Stock (CARL) Earnings
CARL Earnings Reports
Positive Surprise Ratio
CARL beat 4 of 4 last estimates.
100%
Next Report
In 2 Days
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$19.54M
/-$0.40
Implied change from Q2 26 (Revenue/ EPS)
+3.15%
/+2.56%
Implied change from Q3 25 (Revenue/ EPS)
+49.43%
/--
Carlsmed, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, CARL reported earnings of -0.39 USD per share (EPS) for Q2 26, beating the estimate of -0.41 USD, resulting in a 6.30% surprise. Revenue reached 18.94 million, compared to an expected 18.31 million, with a 3.46% difference. The market reacted with a +1.03% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 19.54 million USD, implying an increase of 2.56% EPS, and increase of 3.15% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
FAQ
What were Carlsmed, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Carlsmed, Inc. Common Stock reported EPS of -$0.39, beating estimates by 6.3%, and revenue of $18.94M, 3.46% above expectations.
How did the market react to Carlsmed, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 1.03%, changed from $13.56 before the earnings release to $13.70 the day after.
When is Carlsmed, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Carlsmed, Inc. Common Stock's next earnings report?
Based on 7
analysts, Carlsmed, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of $19.54M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.